|
Market Closed -
Toronto S.E.
14:34:25 2026-10-26 EDT
|
5-day change | 1st Jan Change | ||
| 16.61 CAD | -2.01% |
|
-0.72% | +30.48% |
| 10-18 | BioSyent Inc.(TSXV:RX) added to S&P/TSX Venture Composite Index | CI |
| 09-11 | BioSyent Inc., Q2 2026 Earnings Call, Aug 20, 2026 |
Evolution of the Average Target: BioSyent Inc.
Evolution of the Target Price: BioSyent Inc.
Changes in Analyst Recommendations: BioSyent Inc.
76ae83d25a2e18d214f39.lEVV6IJdUXkpSCuoxIx_lrclmztj-BbDriNrIhZd4E0.5S0MhusJJ0tiGU7iscRHx8BQ630o1Vmxmls6VnIzpX_ZFw_ash41VGB9WA~f3723263572022b92426a20d7481292d
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +6.19% | |||
| +4.56% | |||||
| +5.91% | |||||
| -0.3% | |||||
| -1.16% | |||||
| +9.97% | |||||
| -3.36% | |||||
| +22.49% | |||||
| -9.55% | |||||
| +2.66% | |||||
| Average | +3.74% | |||||
| Weighted average by Cap. | +3.79% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
16.61CAD
Average target price
18.00CAD
Spread / Average Target
+8.37%
High Price Target
18.00CAD
Spread / Highest target
+8.37%
Low Price Target
18.00CAD
Spread / Lowest Target
+8.37%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- RX Stock
- Consensus BioSyent Inc.
Select your edition
All financial news and data tailored to specific country editions
